Skip to main content Deutsch

Webseiten-Inhalte

Detailsite | MedUni Vienna ... Lukas Kenner (MedUni Vienna, Vienna University of Veterinary Medicine and Ludwig Boltzmann Institute for Cancer Research) and including colleagues from Graz and from Germany and Japan has for the first time provided experimental proof that, in an animal model, a blockade of IL-6 brings about significant improvements in SLE.In an earlier publication, the working group headed by Lukas Kenner (Pflegerl et al. 2009 in PNAS) was able to show that, in autoimmune diseases such as SLE, the production of Interleukin 6 (IL-6) from dermal keratinocytes plays a key role in the development and progression of the disease... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?tx_news_pi1%5Bnews%5D=3321&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=fbedb5e988236dfa11c253f56369d9da
Detailsite | MedUni Vienna ... Lukas Kenner (MedUni Vienna, Vienna University of Veterinary Medicine and Ludwig Boltzmann Institute for Cancer Research) and including colleagues from Graz and from Germany and Japan has for the first time provided experimental proof that, in an animal model, a blockade of IL-6 brings about significant improvements in SLE.In an earlier publication, the working group headed by Lukas Kenner (Pflegerl et al. 2009 in PNAS) was able to show that, in autoimmune diseases such as SLE, the production of Interleukin 6 (IL-6) from dermal keratinocytes plays a key role in the development and progression of the disease... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?cHash=fbedb5e988236dfa11c253f56369d9da&tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=3321
Detailsite | MedUni Vienna ... Lukas Kenner (MedUni Vienna, Vienna University of Veterinary Medicine and Ludwig Boltzmann Institute for Cancer Research) and including colleagues from Graz and from Germany and Japan has for the first time provided experimental proof that, in an animal model, a blockade of IL-6 brings about significant improvements in SLE.In an earlier publication, the working group headed by Lukas Kenner (Pflegerl et al. 2009 in PNAS) was able to show that, in autoimmune diseases such as SLE, the production of Interleukin 6 (IL-6) from dermal keratinocytes plays a key role in the development and progression of the disease... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/discovery-of-a-new-approach-to-the-treatment-of-lupus/?L=3
Prostate cancer: specific gene predicts higher survival chances ... a team led by Monika Oberhuber – under the supervision of Lukas Kenner from MedUni Vienna’s Department of Pathology – and the CBmed COMET research centre in Graz has proved that higher levels of the PDK4 gene in tumour tissue can indicate a better prognosis. The study was published in the highly... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-april-2020/prostate-cancer-specific-gene-predicts-higher-survival-chances/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=11&cHash=0078d0f0d52fd2743e452c73393bbe8a
Prostate cancer: specific gene predicts higher survival chances ... a team led by Monika Oberhuber – under the supervision of Lukas Kenner from MedUni Vienna’s Department of Pathology – and the CBmed COMET research centre in Graz has proved that higher levels of the PDK4 gene in tumour tissue can indicate a better prognosis. The study was published in the highly... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-april-2020/prostate-cancer-specific-gene-predicts-higher-survival-chances/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=2&cHash=89a63f68d01265992dea9af4b6debc22
Prostate cancer: specific gene predicts higher survival chances ... a team led by Monika Oberhuber – under the supervision of Lukas Kenner from MedUni Vienna’s Department of Pathology – and the CBmed COMET research centre in Graz has proved that higher levels of the PDK4 gene in tumour tissue can indicate a better prognosis. The study was published in the highly... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-april-2020/prostate-cancer-specific-gene-predicts-higher-survival-chances/?cHash=0078d0f0d52fd2743e452c73393bbe8a&tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=11
Prostate cancer: specific gene predicts higher survival chances ... a team led by Monika Oberhuber – under the supervision of Lukas Kenner from MedUni Vienna’s Department of Pathology – and the CBmed COMET research centre in Graz has proved that higher levels of the PDK4 gene in tumour tissue can indicate a better prognosis. The study was published in the highly... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-april-2020/prostate-cancer-specific-gene-predicts-higher-survival-chances/medicine-science/?L=3
Prostate cancer: specific gene predicts higher survival chances ... a team led by Monika Oberhuber – under the supervision of Lukas Kenner from MedUni Vienna’s Department of Pathology – and the CBmed COMET research centre in Graz has proved that higher levels of the PDK4 gene in tumour tissue can indicate a better prognosis. The study was published in the highly... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-april-2020/prostate-cancer-specific-gene-predicts-higher-survival-chances/?L=3
News ... sein könnte.In dem Projekt arbeitet Christian Seiser auch mit den Forschungsgruppen von Univ. Lektor Ao.Univ. Prof. Mag. Dr. Wolfgang Mikulits am Institut für Krebsforschung und Ao.Univ. Prof. Dr. Lukas Kenner vom Klinischen Institut für Pathologie an der Medizinischen Universität Wien zusammen. „Wir untersuchten die Rolle der Enzyme anhand von Mausmodellen, durch die Kooperation mit klinischen Forschungsgruppen konnten wir die Ergebnisse auch mit menschlichen Tumorzellen vergleichen.“ Dafür war unter anderem die Gruppe von Lukas Kenner gemeinsam mit dem Teratom-Spezialisten Ao.Univ. Prof. Dr. Martin... https://www.meduniwien.ac.at/web/ueber-uns/news/detail/ueberraschende-enzymfunktion-in-der-tumorentwicklung-entdeckt/?L=3
News ... sein könnte.In dem Projekt arbeitet Christian Seiser auch mit den Forschungsgruppen von Univ. Lektor Ao.Univ. Prof. Mag. Dr. Wolfgang Mikulits am Institut für Krebsforschung und Ao.Univ. Prof. Dr. Lukas Kenner vom Klinischen Institut für Pathologie an der Medizinischen Universität Wien zusammen. „Wir untersuchten die Rolle der Enzyme anhand von Mausmodellen, durch die Kooperation mit klinischen Forschungsgruppen konnten wir die Ergebnisse auch mit menschlichen Tumorzellen vergleichen.“ Dafür war unter anderem die Gruppe von Lukas Kenner gemeinsam mit dem Teratom-Spezialisten Ao.Univ. Prof. Dr. Martin... https://www.meduniwien.ac.at/web/index.php?id=131&L=3&tx_news_pi1%5Bnews%5D=425&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=d1f88d9a1aff823513d6447df8548700